An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy.
Izumi Y, Kanayama M, Shen Z, Kai M, Kawamura S, Akiyama M, Yamamoto M, Nagao T, Okada K, Kawamata N, Toyota S, Ohteki T.
Izumi Y, et al. Among authors: shen z.
Front Immunol. 2021 Feb 22;12:618081. doi: 10.3389/fimmu.2021.618081. eCollection 2021.
Front Immunol. 2021.
PMID: 33692791
Free PMC article.